AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Psychopharmacology and Psychiatry Updates
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
Jan 6, 2025
13:34
In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for clinical practice.
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
- Learn more about our membership here
- Earn 0.5 CME: Quick Take Vol. 62
- Antipsychotic Dose Reduction in Schizophrenia: Insights From the RADAR Trial
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode